Clinical Trials

650 enrolled

HER2-positive Breast Cancer

NCT04715958 2026-04-06

SHAPE Neoadjuvant Chemotherapy Response

200 enrolled

Phase 2/3 Active not recruiting

Anatomic Stage III Breast Cancer AJCC v8

NCT03315364 2026-04-01

OPTIMAL

549 enrolled

Breast Neoplasms, Recurrence

NCT06926868 2026-04-01

A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)

500 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07294508 2026-03-20

A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

706 enrolled

Phase 2/3 Active not recruiting

Breast Neoplasms

NCT04191499 2026-03-17

INAVO120

325 enrolled 14 charts 3 FDA

Breast Neoplasms

NCT05766891 2026-03-16

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

225 enrolled

Breast Neoplasms

NCT03077841 2026-03-05

Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer

Phase 2/3 Suspended

928 enrolled

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT07410169 2026-02-13

Efficacy and Safety of Hyperbaric Oxygen Therapy in Improving Nab-paclitaxel-Induced Peripheral Neuropathy

160 enrolled

Breast Neoplasms

NCT06009627 2026-02-10

Study of Neoadjuvant Endocrine Therapy in HR Positive and HER2 Negative Premenopausal Breast Cancer Patients

Phase 2/3 Completed

119 enrolled

Breast Neoplasms

NCT07373782 2026-01-28

Continuous Positive Airway Pressure (CPAP) Assisted Radiotherapy in Breast Cancer

53 enrolled

Microcephaly, Primary Autosomal Recessive, 6, Breast Neoplasms

NCT07366840 2026-01-26

BRIGHT

268 enrolled

Breast Neoplasms

NCT05860465 2026-01-14

Safety and Efficacy of SPH4336 in Combination With Endocrine Therapy in the Treatment of Locally Advanced or Metastatic Breast Cancer

254 enrolled

Phase 2/3 Active not recruiting

Breast Neoplasms

NCT04290793 2026-01-07

Neoadjuvant Chemotherapy With Pyrotinib, Epirubicin and Cyclophosphamide Followed by Taxanes and Trastuzumab for HER-2+ Breast Cancer

113 enrolled

Breast Neoplasms

NCT07310758 2025-12-30

Contrast-enhanced Ultrasound for Sentinel Node Detection

BreastDermatologicHead & Neck

91 enrolled

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT07294534 2025-12-19

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

817 enrolled

Breast Neoplasms

NCT02364557 2025-10-15

Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival

Phase 2/3 Completed

129 enrolled 23 charts

Breast Neoplasms, Lymphatic Metastasis

NCT06891833 2025-10-02

A Study of BL-M07D1 With or Without Pertuzumab Versus Taxane + Trastuzumab and Pertuzumab in Neoadjuvant Therapy for HER2-Positive Breast Cancer

120 enrolled

HER2-positive Breast Cancer

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Phase 2/3 Completed

130 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT05744687 2025-08-17

Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer

374 enrolled

Breast Neoplasms

NCT06958627 2025-05-06

any

964 enrolled